Effects of diamide and iodoacetamide on the expression of the glycoprotein IIb/IIIa complex on blood platelets.
We have examined the effects of two agents that alter platelet thiol-disulphide status on platelet aggregation and on the ability of platelets to bind a monoclonal antibody (M148) that is directed toward an epitope on the glycoprotein IIb/IIIa complex. The immediate effect of both diamide and iodoacetamide is to enhance aggregation but after further incubation diamide, but not iodoacetamide, inhibits platelet aggregation. Incubation of platelets with diamide, but not iodoacetamide, is accompanied by a marked increase in the amount of M148 that binds to platelets. This is presumably a reflection of an altered distribution of glycoproteins on the platelet surface. It is known that diamide, but not iodoacetamide, leads to polymerisation of cytoskeletal proteins in platelets. Thus evidence is provided that agents that interact with the cytoskeleton inhibit platelet behaviour via an effect on surface glycoproteins.
Johnston
G I
GI
Heptinstall
S
S
Lösche
W
W
D000911:Antibodies, Monoclonal; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001391:Azo Compounds / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003958:Diamide / Q000494:pharmacology*; D000939:Epitopes / Q000276:immunology; D006023:Glycoproteins / Q000097:blood* / Q000276:immunology; D006801:Humans; D007158:Immunologic Techniques; D007460:Iodoacetamide / Q000494:pharmacology*; D007461:Iodoacetates / Q000494:pharmacology*; D008565:Membrane Proteins / Q000097:blood* / Q000276:immunology; D010974:Platelet Aggregation / Q000187:drug effects; D010980:Platelet Membrane Glycoproteins
D000911:Antibodies, Monoclonal; D001095:Arachidonic Acids; D001391:Azo Compounds; D000939:Epitopes; D006023:Glycoproteins; D007461:Iodoacetates; D008565:Membrane Proteins; D010980:Platelet Membrane Glycoproteins; D003958:Diamide; D016718:Arachidonic Acid; D007460:Iodoacetamide